[PDF][PDF] Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.

G Akkuzu, C Bes, DS Özgür… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: An increasing number of new on-set autoimmune-inflammatory rheumatic
diseases (AIRD) after COVID-19 vaccination has begun to be reported in the literature. In …

A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond

S Shapira, M Ben Shimon, M Hay‐Levi… - EMBO Molecular …, 2022 - embopress.org
A small but significant proportion of COVID‐19 patients develop life‐threatening cytokine
storm. We have developed a new anti‐inflammatory drug, EXO‐CD24, a combination of an …

[HTML][HTML] Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 Omicron variant infection: A retrospective study of …

P Ying-Hao, G Yuan-Yuan, Z Hai-Dong… - Frontiers in cellular …, 2022 - frontiersin.org
Objectives: To summarize the clinical characteristics of COVID-19 patients infected by
omicron variant of SARS-CoV-2 and explore the risk factors affecting the disease …

[HTML][HTML] Hemophagocytic syndrome and COVID-19: A comprehensive review

MM Fadlallah, SM Salman, MM Fadlallah, H Rahal - Cureus, 2023 - ncbi.nlm.nih.gov
Hemophagocytic lymphohistiocytosis (HLH), a hyperinflammatory hyperferritinemic
syndrome, is triggered by various etiologies and diseases and can lead to multiorgan …

IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition

BS Haslund-Gourley, K Woloszczuk, J Hou… - Nature …, 2024 - nature.com
The glycosylation of IgG plays a critical role during human severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and inducing …

Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infection

T Lu, Q Man, X Yu, S Xia, L Lu, S Jiang… - Frontiers in …, 2023 - frontiersin.org
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant has prevailed globally since November 2021. The extremely high transmissibility and …

Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity

B Wolszczak-Biedrzycka, J Dorf… - Journal of …, 2023 - Taylor & Francis
Introduction In coronavirus disease (COVID-19), inflammation takes center stage, with a
cascade of cytokines released, contributing to both inflammation and lung damage. The …

COVID-19 biology: cytokine storms and their implications

N Atceken, G Kozalak - Stem Cells, 2024 - Elsevier
COVID-19 disease presents in asymptomatic and various symptomatic forms among
individuals. It is thought to be caused by the immune response of individuals. In severe and …

A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of …

M Al. Kharusi, N Al Sheikh, M Alhajri, SA Al. Mandhri… - Healthcare, 2023 - mdpi.com
The COVID-19 pandemic had a profound impact on global health, economies, and social
systems. The crucial factor that determines the success of COVID-19 treatments is …

Identification of biomarkers and pathways for the SARS-CoV-2 infections in obstructive sleep apnea patients based on machine learning and proteomic analysis

H Luo, J Yan, R Gong, D Zhang, X Zhou… - BMC Pulmonary …, 2024 - Springer
Background The prevalence of obstructive sleep apnea (OSA) was found to be higher in
individuals following COVID-19 infection. However, the intricate mechanisms that …